Table 1.
Correlations between miR-211 and clinicopathologic features in melanoma patients.
| Clinicopathological feature | Total 62 | Expression of miR-211 | p Value | |
|---|---|---|---|---|
| Low (%) | High (%) | |||
| Age (years) | ||||
| ≤50 | 21 | 11 (52.4) | 10 (47.6) | 0.744 |
| >50 | 17 | 8 (47.1) | 9 (52.9) | |
| Gender | ||||
| Male | 24 | 13 (54.2) | 11 (45.8) | 0.501 |
| Female | 14 | 6 (42.9) | 8 (57.1) | |
| Ulceration | ||||
| Yes | 23 | 14 (60.9) | 9 (39.1) | 0.097 |
| No | 15 | 5 (33.3) | 10 (66.7) | |
| Tumor thickness | ||||
| ≤2 mm | 16 | 5 (31.3) | 11 (61.7) | 0.049 |
| >2 mm | 22 | 14 (63.6) | 8 (36.4) | |
| Solar elastosis | ||||
| Yes | 19 | 11 (57.9) | 8 (42.1) | 0.330 |
| No | 19 | 8 (42.1) | 11 (57.9) | |
| Metastasis | ||||
| Yes | 17 | 10 | 7 | 0.328 |
| No | 21 | 9 | 12 | |
| AJCC stage | ||||
| I + II | 19 | 6 (31.6) | 13 (68.4) | 0.023 |
| III + iv | 19 | 13 (68.4) | 6 (31.6) | |